Fli-1 expression in malignant melanoma

Histology and Histopathology

Volumn 23, Issue 11, 2008, Pages 1309-1314

  Torlakovic, Emina Emilia ^a   Slipicevic, Ana ^b   Flørenes, Vivi Ann ^b   Chibbar, Richa ^c   DeCoteau, John F ^a   Bilalovic, Nurija ^d  

^a ROYAL UNIVERSITY HOSPITAL   (Canada)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d University of East Sarajevo   (Bosnia and Herzegovina)

Author keywords

Fli 1; Melanoma

Indexed keywords

FORMALDEHYDE; KI 67 ANTIGEN; PARAFFIN; TRANSCRIPTION FACTOR FLI 1; FLI1 PROTEIN, HUMAN; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MELANOMA; MELANOMA CELL; METASTASIS; PRIMARY TUMOR; PROTEIN EXPRESSION; WESTERN BLOTTING; ADULT; AGED; CANCER INVASION; CELL PROLIFERATION; LEUKEMIA CELL LINE; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CELL PROLIFERATION; HUMANS; IMMUNOHISTOCHEMISTRY; JURKAT CELLS; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROTO-ONCOGENE PROTEIN C-FLI-1; TUMOR MARKERS, BIOLOGICAL;

EID: 58149113196     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Baud V., Lipinski M., Rassart E., Poliquin L. and Bergeron D. (1991). The human homolog of the mouse common viral integration region, FLI1, maps to 11q23-q24. Genomics 11, 223-224.
2. Bilalovic N., Sandstad B., Golouh R., Nesland J.M., Selak I. and Torlakovic E.E. (2004). CD10 protein expression in tumor and stromal cells of malignant melanoma is associated with tumor progression. Mod. Pathol. 17, 1251-1258.
3. Cornil I., Theodorescu D., Man S., Herlyn M., Jambrosic J. and Kerbel R.S. (1991). Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc. Natl. Acad. Sci. USA 88, 6028-6032.
4. Delattre O., Zucman J., Plougastel B., Desmaze C., Melot T., Peter M., Kovar H., Joubert I., de Jong P., Rouleau G., Aurias A. and Thomas G. (1992). Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359, 162-165.
5. Dulic V., Lees E. and Reed S.I. (1992). Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257, 1958-1961.
6. Fodstad O., Kjonniksen I., Aamdal S., Nesland J.M., Boyd M.R. and Pihl A. (1988). Extrapulmonary, tissue-specific metastasis formation in nude mice injected with FEMX-I human melanoma cells. Cancer. Res. 48, 4382-4388.
7. Folpe A.L., Chand E.M., Goldblum J.R. and Weiss S.W. (2001). Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics. Am. J. Surg. Pathol. 25, 1061-1066.
8. Hahm K.B., Cho K., Lee C., Im Y.H., Chang J., Choi S.G., Sorensen P.H.B., Thiele C.J. and Kim S.J. (1999). Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWSFLI1 oncoprotein. Nature Genet. 23,222-227
9. Hromas R., May W., Denny C., Raskind W., Moore J., Maki R.A., Beck E. and Klemsz M.J. (1993). Human FLI-1 localizes to chromosome 11q24 and has an aberrant transcript in neuroepithelioma. Biochim. Biophys. Acta 1172, 155-158.
10. Lesault I., Quang C.T., Frampton J. and Ghysdael J. (2002). Direct regulation of BCL-2 by FLI-1 is involved in the survival of FLI-1transformed erythroblasts. EMBO J. 21,694-703.
11. Liang H., Mao X., Olejniczak E.T., Nettesheim D.G., Yu L., Meadows R.P., Thompson C.B. and Fesik S.W. (1994a). Solution structure of the ETS domain of Fli-1 when bound to DNA. Nat. Struct. Biol. 1, 871.
12. Liang H., Olejniczak E.T., Mao X., Nettesheim D.G., Yu L., Thompson C.B. and Fesik S.W. (1994b). The secondary structure of the ETS domain of human Fli-1 resembles that of the helix-turn-helix DNAbinding motif of the Escherichia coli catabolite gene activator protein. Proc. Nat. Acad. Sci. USA 91, 11655.
13. Llombart B., Monteagudo C., Lopez-Guerrero J.A., Carda C., Jorda E., Sanmartin O., Almenar S., Molina I., Martin J.M. and LlombartBosch A. (2005). Clinicopathological and immunohistochemical analysis of 20 cases of Merkel cell carcinoma in search of prognostic markers. Histopathology 46, 622-634.
14. W.A., Gishizky M.L., Lessnick S.L., Lunsford L.B., Lewis B.C., Delattre O., Zucman J., Thomas G. and Denny C.T. (1993). Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc. Nat. Acad. Sci. USA 90, 5752-5756.
15. McCarty K.S. Jr, Miller L.S., Cox E.B., Konrath J. and McCarty K.S. Sr. (1985). Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch. Pathol. Lab. Med. 109, 716-721.
16. Nakatani F., Tanaka K., Sakimura R., Matsumoto Y., Matsunobu T., Li X., Hanada M., Okada T. and Iwamoto Y. (2003). Identification of p21(WAF1/ CIP1) as a direct target of EWS-Fli1 oncogenic fusion protein. J. Biol. Chem. 278, 15105-15115.
17. Pereira R., Quang C.T., Lesault I., Dolznig H., Beug H. and Ghysdael J. (1999). FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts. Oncogene 18, 1597-1608.
18. Prasad D.D., Rao V.N. and Reddy E.S. (1992). Structure and expression of human Fli-1 gene. Cancer Res. 52, 5833-58377.
19. Pusztaszeri M.P., Seelentag W. and Bosman F.T. (2006). Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J. Histochem. Cytochem. 54, 385-395.
20. Rossi S., Orvieto E., Furlanetto A., Laurino L., Ninfo V. and Dei Tos A.P. (2004). Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody. Mod. Pathol. 17, 547-552.
21. Tamir A., Howard J., Higgins R.R., Li Y.J., Berger L., Zacksenhaus E., Reis M. and Ben-David Y. (1999). Fli-1, an Ets-related transcription factor, regulates erythropoietin-induced erythroid proliferation and differentiation: evidence for direct transcriptional repression of the Rb gene during differentiation. Mol. Cell. Biol. 19, 4452-4464.
22. Truong A.H., Cervi D., Lee J. and Ben-David Y. (2005). Direct transcriptional regulation of MDM2 by Fli-1. Oncogene 24, 962-969.